XILIO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 9, 2022, Xilio Therapeutics, Inc. (the "Company") held its 2022 annual meeting of stockholders. The following is a summary of the matters voted on at that meeting and the results of the votes on such matters.

1.The Company's stockholders elected René Russo, Pharm.D. and Sara Bonstein as Class I directors, each to serve for a three-year term expiring at the 2025 annual meeting of stockholders and until her successor has been duly elected and qualified. The results of the stockholders' vote with respect to the election of such Class I directors were as follows:

                     Votes For   Votes Withheld  Broker Non-Votes

René Russo, Pharm.D. 20,085,672 288,051 1,010,384 Sara Bonstein 20,237,758 135,965 1,010,384

2.The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. The results of the stockholders' vote with respect to such ratification were as follows:

Votes For   Votes Against  Votes Abstaining
21,382,138      1,233            736

© Edgar Online, source Glimpses